Dalhousie Medical Research Foundation
Halifax, NS B3H 4R2
Board Chair: Allan Shaw
Vice Board Chair: Janet MacMillian
Charitable Reg. #: 11922 9318 RR0001
Social Results Reporting
Grade: AThe grade is based on the charity's public reporting of the work it does and the results it achieves.
Program Cost Coverage
Full-time staff #5
Avg. Compensation $96,098
Top 10 Staff Salary Range
|$300k - $350k||0|
|$250k - $300k||0|
|$200k - $250k||0|
|$160k - $200k||0|
|$120k - $160k||2|
|$80k - $120k||0|
|$40k - $80k||3|
About Dalhousie Medical Research Foundation:
Founded in 1979, Dalhousie Medical Research Foundation (DMRF) funds medical research at the Dalhousie University Medical School and its related research facilities across the Maritimes. DMRF funds research in four focus areas: cardiovascular research, immunology research, cancer research and neuroscience research.
Research grants made up 88% of Dalhousie Medical Research Foundation's granting activities in F2015. DMRF granted $2.6m in F2015 to researchers whose projects relate to one of DMRF's four focus areas, including $710k to the Beatrice Hunter Cancer Research Institute. The Foundation's spring 2016 Philanthropy report states that Dr. McMaster, one of DMRF's funded researchers, created a new antibiotic that treats the side effects of diabetes and is roughly two years away from FDA approval. Dr. McMaster also developed a drug meant to treat an inherited childhood blinding disease called FEVR. In the laboratory, the drug successfully cured the condition in mice. Dr. McMaster hopes to narrow the gap between this research success and creating a usable drug.
Dalhousie Medical Research Foundation also runs an equipment grants program that distributed $185k in F2015 to researchers requiring financial aid for new equipment purchases. These grants made up 6% of granting activities for the year and helped seven Dalhousie medical researchers, three of which received the Foundation's maximum funding amount of $30k.
Dalhousie Medical Research Foundation also distributes a variety of fellowships, research awards and studentships that help medical students with their research projects and encourage growth in the university's research environment. Combined, these activities accounted for 6% of granting activities in F2015.
Dalhousie Medical Research Foundation is a medium-sized charity with total donations and goods-in-kind revenues of $4.4m in F2015. Investment income totalled $7.3m in F2015, representing an annual return on investment of 11%. DMRF generated investment income of $10.5m in F2014, earning an 18% return on investment. As of F2015, DMRF holds $76.9m in investments, of which 78% are equities.
In-kind donations represents donated shares and these figures are included in donations when calculating DMRF's fundraising ratio.
DMRF holds funding reserves of $76.9m, of which $72.0m (94%) are donor-endowed. Assuming a 5% annual return on DMRF's endowment fund, annual granting activities can be covered indefinitely.
DMRF's endowment funds total just over $72.0m, which grew by 12% within F2015 and 18% within F2014.
This charity report is an update that is currently being reviewed by the Dalhousie Medical Research Foundation. Changes and edits may be forthcoming.
Updated on August 18, 2016 by Katie Khodawandi.
Financial RatiosFiscal year ending March
|Administrative costs as % of revenues||9.0%||11.9%||17.2%|
|Fundraising costs as % of donations||15.1%||19.9%||24.4%|
|Program cost coverage (%)||2,732.8%||2,261.2%||2,227.0%|
Summary Financial StatementsAll figures in $000s
|Goods in kind||1,627||704||518|
|Cash flow from operations||7,796||9,543||4,418|